FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313893466> ?p ?o ?g. }

• W4313893466 endingPage "458" @default.
• W4313893466 startingPage "448" @default.
• W4313893466 abstract "Circulating biomarkers may be useful in understanding prognosis and treatment efficacy in heart failure with reduced ejection fraction. In the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial, vericiguat, a soluble guanylate cyclase stimulator, decreased the primary outcome of cardiovascular death or heart failure hospitalization in heart failure with reduced ejection fraction. We evaluated biomarkers of cardiac injury, inflammation, and renal function for associations with outcomes and vericiguat treatment effect.High-sensitivity cardiac troponin T (hs-cTnT), growth differentiation factor-15 (GDF-15), interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and cystatin C were measured at baseline and 16 weeks. Associations of biomarkers with the primary outcome and its components were estimated. Interaction with study treatment was tested. Changes in biomarkers over time were examined by study treatment. One or more biomarkers were measured in 4652 (92%) of 5050 participants at baseline and 4063 (81%) at 16 weeks. After adjustment, higher values of hs-cTnT, growth differentiation factor-15, and interleukin-6 were associated with the primary outcome, independent of N-terminal pro-B-type natriuretic peptide. Higher hs-cTnT values were associated with a hazard ratio per log standard deviation of 1.21 (95% confidence interval 1.14-1.27). A treatment interaction with vericiguat was evident with hs-cTnT and cardiovascular death (P = .04), but not HF hospitalization (P = .38). All biomarkers except cystatin C decreased over 16 weeks and no relationship between treatment assignment and changes in biomarker levels was observed.hs-cTnT, growth differentiation factor-15, and interleukin-6 levels were associated with risk of the primary outcome in VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction). Uniquely, lower hs-cTnT was associated with a lower rate of cardiovascular death but not HF hospitalization after treatment with vericiguat." @default.
• W4313893466 created "2023-01-10" @default.
• W4313893466 creator A5001281862 @default.
• W4313893466 creator A5003988683 @default.
• W4313893466 creator A5006527198 @default.
• W4313893466 creator A5012849300 @default.
• W4313893466 creator A5015595507 @default.
• W4313893466 creator A5016509111 @default.
• W4313893466 creator A5022314919 @default.
• W4313893466 creator A5023634772 @default.
• W4313893466 creator A5067422552 @default.
• W4313893466 creator A5071573513 @default.
• W4313893466 creator A5074566771 @default.
• W4313893466 creator A5076556121 @default.
• W4313893466 creator A5084514047 @default.
• W4313893466 creator A5089603612 @default.
• W4313893466 creator A5091026533 @default.
• W4313893466 date "2023-04-01" @default.
• W4313893466 modified "2023-10-16" @default.
• W4313893466 title "Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy" @default.
• W4313893466 cites W1945958562 @default.
• W4313893466 cites W1966329493 @default.
• W4313893466 cites W2001164369 @default.
• W4313893466 cites W2003137893 @default.
• W4313893466 cites W2047613631 @default.
• W4313893466 cites W2054214551 @default.
• W4313893466 cites W2071643528 @default.
• W4313893466 cites W2074365605 @default.
• W4313893466 cites W2085051928 @default.
• W4313893466 cites W2126452437 @default.
• W4313893466 cites W2156683561 @default.
• W4313893466 cites W2157973908 @default.
• W4313893466 cites W2163092745 @default.
• W4313893466 cites W2167251312 @default.
• W4313893466 cites W2544208429 @default.
• W4313893466 cites W2584255576 @default.
• W4313893466 cites W2761635900 @default.
• W4313893466 cites W2776010931 @default.
• W4313893466 cites W2784073016 @default.
• W4313893466 cites W2891979996 @default.
• W4313893466 cites W2904656617 @default.
• W4313893466 cites W2913819594 @default.
• W4313893466 cites W2944333322 @default.
• W4313893466 cites W2947746704 @default.
• W4313893466 cites W2955092069 @default.
• W4313893466 cites W3013207865 @default.
• W4313893466 cites W3013323219 @default.
• W4313893466 cites W3013617526 @default.
• W4313893466 cites W3092112220 @default.
• W4313893466 cites W3152832657 @default.
• W4313893466 cites W3162755126 @default.
• W4313893466 cites W3165812848 @default.
• W4313893466 cites W3180092979 @default.
• W4313893466 cites W4225938690 @default.
• W4313893466 doi "https://doi.org/10.1016/j.cardfail.2022.12.013" @default.
• W4313893466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36634811" @default.
• W4313893466 hasPublicationYear "2023" @default.
• W4313893466 type Work @default.
• W4313893466 citedByCount "1" @default.
• W4313893466 countsByYear W43138934662023 @default.
• W4313893466 crossrefType "journal-article" @default.
• W4313893466 hasAuthorship W4313893466A5001281862 @default.
• W4313893466 hasAuthorship W4313893466A5003988683 @default.
• W4313893466 hasAuthorship W4313893466A5006527198 @default.
• W4313893466 hasAuthorship W4313893466A5012849300 @default.
• W4313893466 hasAuthorship W4313893466A5015595507 @default.
• W4313893466 hasAuthorship W4313893466A5016509111 @default.
• W4313893466 hasAuthorship W4313893466A5022314919 @default.
• W4313893466 hasAuthorship W4313893466A5023634772 @default.
• W4313893466 hasAuthorship W4313893466A5067422552 @default.
• W4313893466 hasAuthorship W4313893466A5071573513 @default.
• W4313893466 hasAuthorship W4313893466A5074566771 @default.
• W4313893466 hasAuthorship W4313893466A5076556121 @default.
• W4313893466 hasAuthorship W4313893466A5084514047 @default.
• W4313893466 hasAuthorship W4313893466A5089603612 @default.
• W4313893466 hasAuthorship W4313893466A5091026533 @default.
• W4313893466 hasConcept C111566952 @default.
• W4313893466 hasConcept C126322002 @default.
• W4313893466 hasConcept C136935669 @default.
• W4313893466 hasConcept C144469398 @default.
• W4313893466 hasConcept C159641895 @default.
• W4313893466 hasConcept C164705383 @default.
• W4313893466 hasConcept C185592680 @default.
• W4313893466 hasConcept C207103383 @default.
• W4313893466 hasConcept C2775915353 @default.
• W4313893466 hasConcept C2778198053 @default.
• W4313893466 hasConcept C2779548226 @default.
• W4313893466 hasConcept C2781197716 @default.
• W4313893466 hasConcept C36036425 @default.
• W4313893466 hasConcept C44249647 @default.
• W4313893466 hasConcept C500558357 @default.
• W4313893466 hasConcept C55493867 @default.
• W4313893466 hasConcept C71924100 @default.
• W4313893466 hasConcept C78085059 @default.
• W4313893466 hasConcept C8880881 @default.
• W4313893466 hasConceptScore W4313893466C111566952 @default.
• W4313893466 hasConceptScore W4313893466C126322002 @default.
• W4313893466 hasConceptScore W4313893466C136935669 @default.

• next